Skip to content
1. Pancreatic Cancer:
- To collect organize the data patients that have been treated with low dose combination chemotherapy.
- To report response rates, survival and toxicity.
- To publish the results in the appropriate journals.
- To validate and establish this approach and serve as a backbone for further trials.
- To raise awareness and obtain funding from advocacy groups to explore new therapies in patients who have failed standard therapy or for patient’s who would not tolerate standard dose combination chemotherapy (conventional clinical trials are not typically designed to tailor to this patient population).
2. Ovarian Cancer
- To collect organize the data on patients that have been treated with low dose combination chemotherapy.
- To report response rates, survival and toxicity.
- To publish the results in the appropriate journals.
- To validate and establish this approach and serve as a backbone for further trials.
3. Cholangiocarcinoma
- To collect, organize, and analyze the existing data on patients that have been treated with low dose combination chemotherapy.
- To report response rates, survival and toxicity.
- To publish the results in the appropriate journals.
- To validate and establish this approach and serve as a backbone for further trials
- To raise awareness and obtain funding to explore new therapies in patients with this relatively rare cancer because resources are not as available.
4. Case reports in Adrenal cortical carcinoma, Sarcoma, and Kidney Cancer
- To collect, organize, the data on individual patients that have been treated successfully with low dose combination chemotherapy.
